The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakatsume, M.
Right arrow Articles by Finbloom, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakatsume, M.
Right arrow Articles by Finbloom, D. S.

The Journal of Immunology, Vol 156, Issue 11 4160-4166, Copyright © 1996 by American Association of Immunologists


ARTICLES

Modulation of the expression of the IFN-gamma receptor beta-chain controls responsiveness to IFN-gamma in human peripheral blood T cells

M Sakatsume and DS Finbloom
Food and Drug Administration, Center for Biologics Research and Evaluation, Division of Cytokine Biology, Bethesda, MD 20892, USA.

IFN-gamma has potent antiproliferative and apoptotic effects in T cells that are important in determining T cell development and polarized differentiation. Therefore, any event that enables T cells to become less responsive to IFN- gamma may potentially alter immune responsiveness to Ag. In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription. This nonresponsiveness occurs because of a lack of expression of the beta- chain (accessory factor) of the IFN-gamma receptor, while at the same time maintaining IFN-gamma receptor alpha-chain expression. Expression of the beta-chain can be restored by secondary TCR ligation or PMA treatment. T cell blasts treated with PMA are now responsive to IFN-gamma. When freshly isolated, highly enriched (>98%) T cells are examined for IFN-gamma responsiveness; these cells can respond to IFN-gamma and express beta- chain. Therefore, as T cells progress from primary TCR activation through IL-2-dependent proliferation, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.


This article has been cited by other articles:


Home page
BloodHome page
L. Conti, G. Regis, A. Longo, P. Bernabei, R. Chiarle, M. Giovarelli, and F. Novelli
In the absence of IGF-1 signaling, IFN-{gamma} suppresses human malignant T-cell growth
Blood, March 15, 2007; 109(6): 2496 - 2504.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Plaza, J. L. Rodriguez-Sanchez, and C. Juarez
Staphylococcal Enterotoxin B In Vivo Modulates both Gamma Interferon Receptor Expression and Ligand-Induced Activation of Signal Transducer and Activator of Transcription 1 in T Cells
Infect. Immun., January 1, 2007; 75(1): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Regis, M. Bosticardo, L. Conti, S. De Angelis, D. Boselli, B. Tomaino, P. Bernabei, M. Giovarelli, and F. Novelli
Iron regulates T-lymphocyte sensitivity to the IFN-{gamma}/STAT1 signaling pathway in vitro and in vivo
Blood, April 15, 2005; 105(8): 3214 - 3221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Rosenzweig, O. M. Schwartz, M. R. Brown, T. L. Leto, and S. M. Holland
Characterization of a Dipeptide Motif Regulating IFN-{gamma} Receptor 2 Plasma Membrane Accumulation and IFN-{gamma} Responsiveness
J. Immunol., September 15, 2004; 173(6): 3991 - 3999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Rosenzweig, S. E. Dorman, G. Uzel, S. Shaw, A. Scurlock, M. R. Brown, R. H. Buckley, and S. M. Holland
A Novel Mutation in IFN-{gamma} Receptor 2 with Dominant Negative Activity: Biological Consequences of Homozygous and Heterozygous States
J. Immunol., September 15, 2004; 173(6): 4000 - 4008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hosui, K. Ohkawa, H. Ishida, A. Sato, F. Nakanishi, K. Ueda, T. Takehara, A. Kasahara, Y. Sasaki, M. Hori, et al.
Hepatitis C Virus Core Protein Differently Regulates the JAK-STAT Signaling Pathway under Interleukin-6 and Interferon-{gamma} Stimuli
J. Biol. Chem., August 1, 2003; 278(31): 28562 - 28571.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Sakatsume, Y. Xie, M. Ueno, H. Obayashi, S. Goto, I. Narita, N. Homma, K. Tasaki, Y. Suzuki, and F. Gejyo
Human Glomerulonephritis Accompanied by Active Cellular Infiltrates Shows Effector T Cells in Urine
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2636 - 2644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Stamme, E. Walsh, and J. R. Wright
Surfactant Protein A Differentially Regulates IFN-gamma - and LPS-Induced Nitrite Production by Rat Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 772 - 779.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Skrenta, Y. Yang, S. Pestka, and C. G. Fathman
Ligand-Independent Down-Regulation of IFN-{gamma} Receptor 1 Following TCR Engagement
J. Immunol., April 1, 2000; 164(7): 3506 - 3511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hussain, B. S. Zwilling, and W. P. Lafuse
Mycobacterium avium Infection of Mouse Macrophages Inhibits IFN-{gamma} Janus Kinase-STAT Signaling and Gene Induction by Down-Regulation of the IFN-{gamma} Receptor
J. Immunol., August 15, 1999; 163(4): 2041 - 2048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Castro, T. K. Sengupta, D. C. Ruiz, E. Yang, and L. B. Ivashkiv
IL-4 Selectively Inhibits IL-2-Triggered Stat5 Activation, But Not Proliferation, in Human T Cells
J. Immunol., February 1, 1999; 162(3): 1261 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Bovolenta, A. L. Lorini, B. Mantelli, L. Camorali, F. Novelli, P. Biswas, and G. Poli
A Selective Defect of IFN-{gamma}- But Not of IFN-{alpha}-Induced JAK/STAT Pathway in a Subset of U937 Clones Prevents the Antiretroviral Effect of IFN-{gamma} Against HIV-1
J. Immunol., January 1, 1999; 162(1): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. F. Stancato, C.-R. Yu, E. F. Petricoin III, and A. C. Larner
Activation of Raf-1 by Interferon gamma  and Oncostatin M Requires Expression of the Stat1 Transcription Factor
J. Biol. Chem., July 24, 1998; 273(30): 18701 - 18704.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Lu, C. Ebensperger, Z. Dembic, Y. Wang, M. Kvatyuk, T. Lu, R. L. Coffman, S. Pestka, and P. B. Rothman
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice
PNAS, July 7, 1998; 95(14): 8233 - 8238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sakatsume, L. F. Stancato, M. David, O. Silvennoinen, P. Saharinen, J. Pierce, A. C. Larner, and D. S. Finbloom
Interferongamma Activation of Raf-1 Is Jak1-dependent and p21ras-independent
J. Biol. Chem., January 30, 1998; 273(5): 3021 - 3026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.